Cancer Research Institute/LinkedIn
Jul 10, 2025, 08:26
New Mechanism Revealed for Tumor Influence on Innate Immunity, Offering Promising Path for Immunotherapy – CRI
Cancer Research Institute (CRI) shared a post on LinkedIn:
“In a new study published in Springer Nature‘s Nature Immunology, researchers from Humanitas Research Hospital including CRI Lloyd J. Old STAR Dr. Enrico Lugli describe a mechanism through which tumors influence the functioning of innate immunity to their advantage, identifying the receptors regulating the pro-tumoral transformation of macrophages for the first time. Preventing the activation of these chemosensors by the tumor would constitute a new approach to immunotherapy based on innate immunity, a path yet to be deeply explored. Read more.”
More posts featuring Cancer Research Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 2, 2025, 00:00
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32